2023
Defining the denominator for measuring quality of end-of-life care in children with cancer: Results of a nominal group technique.
Johnston E, Tefera R, Ananth P, Martinez I, Porter A, Snaman J, Thienprayoon R, Asch S, Bhatia S, O'Beirne R. Defining the denominator for measuring quality of end-of-life care in children with cancer: Results of a nominal group technique. JCO Oncology Practice 2023, 19: 227-227. DOI: 10.1200/op.2023.19.11_suppl.227.Peer-Reviewed Original ResearchEOL quality measuresPoor-prognosis cancerQuality of EOLSpecific treatment scenarioNominal group techniqueHigh-quality EOL carePediatric palliative carePediatric critical careQuality of endNon-Hispanic whitesNational Quality ForumClinical program developmentAdvanced diseasePalliative carePediatric oncologyEOL careCritical careLife careStage IIIHospice cliniciansCertain symptomsCancerQuality ForumLife quality measuresTreatment scenarios
2021
Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer
Oberoi S, Protudjer JLP, Rapoport A, Rassekh SR, Crooks B, Siden H, Decker K, Ananth P, Chapman S, Balneaves LG, Vanan MI, Kelly LE. Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer. Cancer Reports 2021, 5: e1551. PMID: 34672127, PMCID: PMC9458513, DOI: 10.1002/cnr2.1551.Peer-Reviewed Original ResearchConceptsPalliative care physiciansCare physiciansPediatric oncologistsCannabis-related researchPediatric oncology patientsManagement of nauseaMost pediatric oncologistsSafety of cannabisPotential roleUse of cannabisSymptom controlPoor appetiteSymptom reliefChronic painOncology patientsPediatric oncologySide effectsMedical cannabisOncologistsTherapeutic useAnticancer effectsPhysiciansCancerSurvey domainsCannabisA Stakeholder-Driven Qualitative Study to Define High Quality End-of-Life Care for Children With Cancer
Ananth P, Mun S, Reffat N, Li R, Sedghi T, Avery M, Snaman J, Gross CP, Ma X, Wolfe J. A Stakeholder-Driven Qualitative Study to Define High Quality End-of-Life Care for Children With Cancer. Journal Of Pain And Symptom Management 2021, 62: 492-502. PMID: 33556497, PMCID: PMC8339188, DOI: 10.1016/j.jpainsymman.2021.01.134.Peer-Reviewed Original ResearchConceptsHigh-quality endQuality EOLCAdvanced cancerSymptom managementLife careQuality endLocation of deathMulticenter qualitative studyAvoidance of hospitalizationPerson-centered measuresCancer stakeholdersEnd of lifeSupportive careMechanical ventilationParents of childrenEmergency departmentInterdisciplinary careInterdisciplinary healthcare professionalsCardiopulmonary resuscitationHospice careQualitative studyCancerHealthcare professionalsFamily preferencesYoung adults
2020
Parent Perceptions of Team-Delivered Care for Children With Advanced Cancer: A Report From the PediQUEST Study
Feraco AM, Ananth P, Dussel V, Al-Sayegh H, Ma C, Rosenberg AR, Feudtner C, Wolfe J. Parent Perceptions of Team-Delivered Care for Children With Advanced Cancer: A Report From the PediQUEST Study. Journal Of Pain And Symptom Management 2020, 60: 811-817. PMID: 32450115, PMCID: PMC7508972, DOI: 10.1016/j.jpainsymman.2020.05.019.Peer-Reviewed Original ResearchConceptsAdvanced cancerCare teamIndividual cliniciansExact testCare qualityRatings of careFisher's exact testHealth care teamSymptom management trialsParents' perceptionsChildhood cancer careCross-sectional surveyOne-third reportInterprofessional health care teamsCare of childrenClinician typePediQUEST studyPrimary outcomeParents of childrenCancer careAssociated FactorsRefractory cancerChild's oncologistExcellent careCancer
2018
Provider Perspectives on Use of Medical Marijuana in Children With Cancer
Ananth P, Ma C, Al-Sayegh H, Kroon L, Klein V, Wharton C, Hallez E, Braun I, Michelson K, Rosenberg AR, London W, Wolfe J. Provider Perspectives on Use of Medical Marijuana in Children With Cancer. Pediatrics 2018, 141: e20170559. PMID: 29233937, PMCID: PMC5744275, DOI: 10.1542/peds.2017-0559.Peer-Reviewed Original ResearchConceptsPediatric oncology providersMedical marijuanaOncology providersMM useProvider perspectivesCancer-directed therapyPercent of providersCross-sectional surveyLogistic regression modelsWilcoxon rank testSupportive careMedian ageOral formulationMM practiceSerious illnessMost providersGroup comparisonsCancerPrevious monthRank testState-specific regulationsChildrenRegression modelsImportant barriersGreatest barrier
2017
Medical marijuana in pediatric oncology: A review of the evidence and implications for practice
Ananth P, Reed‐Weston A, Wolfe J. Medical marijuana in pediatric oncology: A review of the evidence and implications for practice. Pediatric Blood & Cancer 2017, 65 PMID: 28926679, DOI: 10.1002/pbc.26826.Peer-Reviewed Original ResearchConceptsMedical marijuanaPediatric oncologyCancer-related symptomsPediatric oncology patientsSupportive care agentsMechanism of actionSupportive carePediatric patientsOncology patientsSerious illnessCare agentsPatientsOncologyMarijuanaPotential benefitsPurported benefitsFuture investigationsReviewSymptomsIllnessCancerCareInfluence of early phase clinical trial enrollment on patterns of end‐of‐life care for children with advanced cancer
Ananth P, Monsereenusorn C, Ma C, Al‐Sayegh H, Wolfe J, Rodriguez‐Galindo C. Influence of early phase clinical trial enrollment on patterns of end‐of‐life care for children with advanced cancer. Pediatric Blood & Cancer 2017, 65 PMID: 28771913, DOI: 10.1002/pbc.26748.Peer-Reviewed Original ResearchConceptsEarly phase clinical trialsTrial enrollmentAdvanced cancerHealthcare utilizationLife careRetrospective cohort studyPediatric oncology patientsClinical trial enrollmentPhase clinical trialsPatterns of endNeP patientsBaseline characteristicsCohort studyOncology patientsEP patientsPPC consultationClinical trialsCare receiptPatientsCancerEnrollmentCareFuture studiesChildrenEOLC